History of malignancy is a predictor of prostate cancer detection: Incorporation into a pre-biopsy nomogram: Original article: Clinical investigation

International Journal of Urology

Volumn 15, Issue 12, 2008, Pages 1055-1060

  Kawakami, Satoru ^a   Koga, Fumitaka ^a   Fujii, Yasuhisa ^a   Saito, Kazutaka ^a   Yamamoto, Shinya ^b   Tatokoro, Manabu ^a   Yonese, Junji ^b   Kageyama, Yukio ^a   Fukui, Iwao ^b   Kihara, Kazunori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Biopsy; Family history; Multiple primary malignant neoplasms; Nomogram; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANAMNESIS; ARTICLE; BODY MASS; CANCER CYTODIAGNOSIS; CLINICAL DECISION MAKING; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; HUMAN; HUMAN TISSUE; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NOMOGRAM; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; UNIVARIATE ANALYSIS;

AGED; BIOPSY; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 57449092886     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02183.x     Document Type: Article

References (25)

1. Yancik R. Population aging and cancer: A cross-national concern. Cancer J. 2005 11 : 437 41.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin. 2008 58 : 71 96.
3. Tsukuma H, Fujimoto I, Hanai A, Hiyama T, Kitagawa T, Kinoshita N. Incidence of second primary cancers in Osaka residents, Japan, with special reference to cumulative and relative risks. Jpn J. Cancer Res. 1994 85 : 339 45.
4. Gotay CC, Ransom S, Pagano IS. Quality of life in survivors of multiple primary cancers compared with cancer survivor controls. Cancer 2007 110 : 2101 9.
5. Kawakami S, Kihara K, Fujii Y, Masuda H, Kobayashi T, Kageyama Y. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer. Int. J. Urol. 2004 11 : 613 18.
6. Kawakami S, Hyochi N, Yonese J et al. Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer. Int. J. Clin. Oncol. 2006 11 : 127 32.
7. Scattoni V, Zlotta A, Montironi R, Schulman C, Rigatti P, Montorsi F. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: A critical analysis of the literature. Eur. Urol. 2007 52 : 1309 22.
8. Walz J, Graefen M, Chun FK et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur. Urol. 2006 50 : 498 505.
9. Chun FK, Briganti A, Graefen M et al. Development and external validation of an extended 10-core biopsy nomogram. Eur. Urol. 2007 52 : 436 44.
10. Kawamura K, Suzuki H, Kamiya N et al. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL. Int. J. Urol. 2008 15 : 598 603.
11. Kawakami S, Numao A, Okubo Y et al. Development, validation and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur. Urol. 2008 54 : 601 11.
12. Grönberg H. Prostate cancer epidemiology. Lancet 2003 361 : 859 64.
13. Bostwick DG, Burke HB, Djakiew D et al. Human prostate cancer risk factors. Cancer 2004 101 : 2371 490.
14. Shibata A, Whittemore AS. Genetic predisposition to prostate cancer: Possible explanations for ethnic differences in risk. Prostate 1997 32 : 65 72.
15. Stanford J, Stephenson R, Coyle L. Prostate Cancer Trends 1973-1995. National Institutes of Health Publication 99-4543. Bethesda, MD : National Institutes of Health, 1999.
16. Kalish LA, McDougal WS, McKinlay JB. Family history and the risk of prostate cancer. Urology 2000 56 : 803 6.
17. Yanke BV, Carver BS, Bianco FJ Jr. et al. African-American race is a predictor of prostate cancer detection: Incorporation into a pre-biopsy nomogram. BJU Int. 2006 98 : 783 7.
18. Heidenreich A, Aus G, Bolla M et al. EAU guidelines on prostate cancer. Eur. Urol. 2008 53 : 68 80.
19. National Comprehensive Cancer Network. Practice NCCN Guidelines in Oncology - Prostate Cancer Early Detection, v.2.2007. [Cited 30 Nov 2007.] Available from URL: http://www.nccn.org/professionals/physician-gls/PDF/ prostate-detection.pdf
20. Kawakami S, Okuno T, Yonese J et al. Optimal sampling sites for repeat prostate biopsy: A recursive partitioning analysis of three-dimensional 26-core systematic biopsy. Eur. Urol. 2007 51 : 675 83.
21. Kawakami S, Yamamoto S, Numao N, Ishikawa Y, Kihara K, Fukui I. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int. J. Urol. 2007 14 : 719 24.
22. Suzuki T, Matsuo K, Wakai K et al. Effect of familial history and smoking on common cancer risks in Japan. Cancer 2007 109 : 2116 23.
23. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am. J. Epidemiol. 2000 151 : 541 9.
24. Giovannucci E, Rimm EB, Liu Y et al. Body mass index and risk of prostate cancer in U.S. health professionals. J. Natl. Cancer Inst. 2003 95 : 1240 4.
25. Freedland SJ, Platz EA. Obesity and prostate cancer: Making sense out of apparently conflicting data. Epidemiol. Rev. 2007 29 : 88 97.